BSAC standardized disc susceptibility testing method (version 6)

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 1, 2007, Pages 20-41

  Andrews, Jenny M ^a  

^a CITY HOSPITAL   (United Kingdom)

Author keywords

Breakpoints; Disc testing; MICs

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AZTREONAM; CARBAPENEM DERIVATIVE; CEFACLOR; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; DAPTOMYCIN; ERTAPENEM; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MONOBACTAM DERIVATIVE; MOXIFLOXACIN; NETILMICIN; NORFLOXACIN; OFLOXACIN; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; TEICOPLANIN; TIGECYCLINE; UNINDEXED DRUG;

ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; DIFFUSION; DRUG HALF LIFE; DRUG POTENCY; ENTEROCOCCUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IN VITRO STUDY; LABORATORY TEST; MICROORGANISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHARMACODYNAMICS; RESPIRATORY TRACT INFECTION; STANDARDIZATION; STAPHYLOCOCCUS; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CULTURE MEDIA; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE COCCI; GREAT BRITAIN; HUMANS; MICROBIAL SENSITIVITY TESTS; REFERENCE STANDARDS;

EID: 34447581099     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm110     Document Type: Article

References (9)

1. Andrews JM. BSAC standardised disc susceptibility testing method (version 5). J Antimicrob Chemother 2006; 58: 511-29.
2. British Society for Antimicrobial Chemotherapy. A guide to sensitivity testing. J Antimicrob Chemother 1991; 27 Suppl D: 1-50.
3. Andrews JM, Brown DFJ, Wise R. A survey of antimicrobial susceptibility testing in the United Kingdom. J Antimicrob Chemother 1996; 37 187-8.
4. Andrews JM. The development of the BSAC standardized method of disc diffusion testing. J Antimicrob Chemother 2001; 48 Suppl 1: 29-42.
5. Inderlied CB, Nash KA. Antimycobacterial agents. In vitro susceptibility testing, spectra of activity, mechanisms of action and resistance, and assays for activity in biologic fluids. In: Lorian V ed. Antibiotics in Laboratory Medicine. Baltimore, MD, USA: Williams and Wilkins, 1996; 127-75.
6. Brown DFJ. Detection of methicillin/oxacillin resistance in staphylococci. J Antimicrob Chemother 2001; 48 Suppl 1: 65-70.
7. Moosdeen F, Williams JD, Secker A. Standardization of inoculum size for disc susceptibility testing: A preliminary report of a spectrophotometric method. J Antimicrob Chemother 1988; 21: 439-43.
8. Harbath S, Liassine N, Dharan S et al. Risk factors for persistent carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 2000; 31: 1380-5.
9. Elliott TSJ, Foweraker J, Gould FK et al. Guidelines for the antibiotic treatment of endocarditis in adults: Report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54: 971-81.